Weight Loss Medication in Manchester
For people seeking information about the weight loss drug Tirzepatide (Mounjaro). This is not currently available on NHS prescription anywhere in Greater Manchester, including GP practices, pharmacies, hospitals, or specialist weight management services.
Support with weight management
The NHS provides a wide range of advice and tools to support healthy weight loss.
We understand that many people are looking for support in managing their weight.
Here in Greater Manchester, we’re working hard to improve access to services and new treatments for people living with obesity.Support with weight management
New Medication for Weight Loss: Tirzepatide (Mounjaro®)
What is Tirzepatide (Mounjaro®)?
- Tirzepatide (brand name Mounjaro®) is a new medication recently recommended by the National Institute for Health and Care Excellence (NICE) for some adults living with obesity.
- It helps reduce hunger, increases feeling of fullness, and supports weight loss by helping you eat less and improving how your body uses food and controls blood sugar.
- Tirzepatide is given as a weekly injection, which you can administer yourself.
- Tirzepatide must be prescribed as part of a support programme, also known as wraparound care. This includes advice on healthy eating, physical activity, and lifestyle changes.
You must agree to take part in this support in order to receive the medication.
Important: Tirzepatide (Mounjaro®) is not available to everyone right away. It will be rolled out gradually across England, starting with people who have the most urgent clinical needs.
Eligibility is based on Body Mass Index (BMI) and certain health conditions.
We know that managing weight can be incredibly challenging, and many people are asking about Mounjaro (tirzepatide) after hearing about how effective it can be in helping with weight loss.
As your Integrated Care Board (ICB), as well as following the national guidance, we also have to make sure treatments are used fairly and within the budget we have available for our whole population.
We appreciate that this might feel frustrating, especially when private options are being advertised.
Frequently Asked Questions
To see frequently asked questions please visit the Greater Manchester Intergrated Care Boards website.
What’s next?
GMICB will provide more updates in late June 2025, including:
- When the new services will become available in GP practices, and whether access through community pharmacies will also be included
- How eligible patients will be identified and contacted
- What support and information will be available when treatment begins
Thank you for your patience as we work to bring this new treatment to those who need it most. Our priority is to ensure safe, fair, and effective care for everyone in Greater Manchester.